New Insights into the Treatment of Valvular Heart Disease

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1646

Special Issue Editors


E-Mail Website
Guest Editor
Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy Iasi, 16 University Street, 700115 Iasi, Romania
Interests: cardiology; internal medicine; heart failure; atherosclerosis; arterial hypertension
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Faculty of Medicine, “George Emil Palade” University o Medicine, Pharmacy, Science and Technology of Targu Mures, 38 Gheorghe Marinescu Street, 54042 Targu Mures, Romania
Interests: vulnerable plaques; atherosclerosis; heart failure; acute coronary syndromes; interventional cardiology
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, Square Eftimie Murgu No. 2, 30041 Timisoara, Romania
Interests: cardiology; internal medicine; heart failure; atherosclerosis; arterial hypertension
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cardiovascular diseases represent the main cause of mortality worldwide, and valvular heart diseases (VHD) are among the most frequent. In recent years, the interventional treatment of VHD, mainly via transcatheter aortic valve replacement (TAVI), has begun to replace traditional open heart surgery for aortic valve corrections in many health centers, and has rapidly become the first-option therapy for several clinical conditions; meanwhile, interventional mitral valve correction using MitraClip devices has demonstrated good results in patients with heart failure and mitral insufficiency. The immediate and long-term results of an interventional procedure depend largely on the complexity and the accuracy of the image-based pre-operative assessment of the lesions. As a result of the impressive technological progress made in recent years, many new cardiac imaging methods have been developed that aim to better characterize heart diseases and provide the necessary information required for complex cardiac interventions. These include new applications of advanced 3D echocardiography and multislice cardiac computed tomography with computerized and complex 3D-based reconstructions of cardiac structures.

This Special Issue will highlight the most recent advances in the diagnostics and treatment of VHD, focusing on multimodal imaging for diagnosing VHD, modern technologies for pre-intervention assessment, and novel therapeutic techniques for the correction of diseased valves.   

Prof. Dr. Ciprian Rezus
Dr. Theodora Benedek
Prof. Dr. Daniel Florin Lighezan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • valvular heart diseases
  • imaging
  • TAVI

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 305 KiB  
Review
Modern Treatment of Valvulopathies in Patients with Congenital Hemophilia
by Minerva Codruta Badescu, Oana Viola Badulescu, Liliana Gheorghe, Lăcrămioara Ionela Butnariu, Anca Ouatu, Diana Popescu, Oana Nicoleta Buliga-Finiș, Eusebiu Vlad Gorduza, Manuela Ciocoiu and Ciprian Rezus
Life 2024, 14(3), 354; https://doi.org/10.3390/life14030354 - 7 Mar 2024
Viewed by 1298
Abstract
Hemophiliacs can develop cardiovascular diseases, including valvulopathies of various etiologies and severities. Some require surgical treatment. Performing cardiac surgery in hemophiliacs is a challenge because they maintain an increased risk of bleeding throughout their lives. Our review shows that with a multidisciplinary team [...] Read more.
Hemophiliacs can develop cardiovascular diseases, including valvulopathies of various etiologies and severities. Some require surgical treatment. Performing cardiac surgery in hemophiliacs is a challenge because they maintain an increased risk of bleeding throughout their lives. Our review shows that with a multidisciplinary team and careful planning, cardiac surgery can be safely performed in these patients. Valve repair and bioprosthetic valves should be preferred over mechanical valves to avoid life-long anticoagulation. In patients who cannot receive a bioprosthetic valve, the use of the On-X mechanical valve might be considered because it requires less intensive anticoagulation after 3 months of treatment. Antithrombotic treatment is feasible in hemophiliacs only if the coagulation factor level is kept constantly above a specific trough limit. Our review is valuable because, for the first time, the available data on the modern surgical treatment of valvular disease in hemophiliacs have been synthesized and systematized. Full article
(This article belongs to the Special Issue New Insights into the Treatment of Valvular Heart Disease)
Back to TopTop